share_log
Breakings ·  Jun 13 19:02
Moderna - Mrna-1283 Has Now Met Its Primary Vaccine Efficacy Endpoint in Phase 3
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment